multicenter non-randomized non-blind exploratory clinical trial of safety and efficacy of cidofovir for adenovirus infection after hematopoietic stem cell transplantatio
Not Applicable
- Conditions
- adenovirus infection after hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000011158
- Lead Sponsor
- orth Japan Hematology Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Allergy to drugs used in this trial 2. Serum creatinine higher than 1.5 mg/dl (In case of renal dysfunction by viral infection, higher than 2.5 mg/dl) 3. History of receiving foscarnet 4. During pregnancy, breastfeeding or potential pregnancy 5. Patients who are recognized as inadaptable for this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method